Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (PIK Dividend or Equity Fee Payable) (Details)

v3.23.1
Related Party Transactions (PIK Dividend or Equity Fee Payable) (Details)
 12 Months Ended
Dec. 31, 2022
Aevitas [Member]  
Related Party Transaction [Line Items]  
Effective date Jul. 28, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Avenue Therapeutics, Inc [Member]  
Related Party Transaction [Line Items]  
Effective date Feb. 17, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Baergic [Member]  
Related Party Transaction [Line Items]  
Effective date Dec. 17, 2019
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Annual equity fee as a percentage of fully diluted outstanding capitalization 2.50%
Cellvation [Member]  
Related Party Transaction [Line Items]  
Effective date Oct. 31, 2016
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Checkpoint [Member]  
Related Party Transaction [Line Items]  
Effective date Mar. 17, 2015
Cyprium [Member]  
Related Party Transaction [Line Items]  
Effective date Mar. 13, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Helocyte [Member]  
Related Party Transaction [Line Items]  
Effective date Mar. 20, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Mustang  
Related Party Transaction [Line Items]  
Effective date Mar. 13, 2015
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Oncogenuity [Member]  
Related Party Transaction [Line Items]  
Effective date Apr. 22, 2020
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%
Urica  
Related Party Transaction [Line Items]  
Effective date Nov. 07, 2017
PIK dividend as a percentage of fully diluted outstanding capitalization 2.50%